Mette V Larsen
Overview
Explore the profile of Mette V Larsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
2048
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zschach H, Larsen M, Hasman H, Westh H, Nielsen M, Miedzybrodzki R, et al.
Antibiotics (Basel)
. 2018 Feb;
7(1).
PMID: 29382143
is a major agent of nosocomial infections. Especially in methicillin-resistant strains, conventional treatment options are limited and expensive, which has fueled a growing interest in phage therapy approaches. We have...
2.
Zschach H, Joensen K, Lindhard B, Lund O, Goderdzishvili M, Chkonia I, et al.
Viruses
. 2015 Dec;
7(12):6570-89.
PMID: 26703713
Phage therapy, a practice widespread in Eastern Europe, has untapped potential in the combat against antibiotic-resistant bacterial infections. However, technology transfer to Western medicine is proving challenging. Bioinformatics analysis could...
3.
Saputra D, Rasmussen S, Larsen M, Haddad N, Maddalena Sperotto M, Aarestrup F, et al.
BMC Bioinformatics
. 2015 Nov;
16:398.
PMID: 26608174
Background: Identification of bacteria may be based on sequencing and molecular analysis of a specific locus such as 16S rRNA, or a set of loci such as in multilocus sequence...
4.
Bonde M, Makransky G, Wandall J, Larsen M, Morsing M, Jarmer H, et al.
Nat Biotechnol
. 2014 Jul;
32(7):694-7.
PMID: 25004234
No abstract available.
5.
Larsen M, Cosentino S, Lukjancenko O, Saputra D, Rasmussen S, Hasman H, et al.
J Clin Microbiol
. 2014 Feb;
52(5):1529-39.
PMID: 24574292
One of the first issues that emerges when a prokaryotic organism of interest is encountered is the question of what it is--that is, which species it is. The 16S rRNA...
6.
Perez C, Milush J, Buggert M, Eriksson E, Larsen M, Liegler T, et al.
AIDS Res Hum Retroviruses
. 2012 Nov;
29(3):602-12.
PMID: 23140171
We aimed to investigate whether the character of the immunodominant HIV-Gag peptide (variable or conserved) targeted by CD8(+) T cells in early HIV infection would influence the quality and quantity...
7.
Stranzl T, Larsen M, Lund O, Nielsen M, Brunak S
PLoS One
. 2012 Oct;
7(9):e38670.
PMID: 23049726
Several studies have shown that cancers actively regulate alternative splicing. Altered splicing mechanisms in cancer lead to cancer-specific transcripts different from the pool of transcripts occurring only in healthy tissue....
8.
Larsen M, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig R, et al.
J Clin Microbiol
. 2012 Jan;
50(4):1355-61.
PMID: 22238442
Accurate strain identification is essential for anyone working with bacteria. For many species, multilocus sequence typing (MLST) is considered the "gold standard" of typing, but it is traditionally performed in...
9.
Wang M, Tang S, Stryhn A, Justesen S, Larsen M, Dziegiel M, et al.
Immunology
. 2011 Feb;
132(4):482-91.
PMID: 21294723
Major histocompatibility complex (MHC) class I restricted cytotoxic T lymphocytes (CTL) are known to play an important role in the control of Mycobacterium tuberculosis infection so identification of CTL epitopes...
10.
Wang M, Larsen M, Nielsen M, Harndahl M, Justesen S, Dziegiel M, et al.
PLoS One
. 2010 May;
5(5):e10533.
PMID: 20479886
Background: Identification of human leukocyte antigen class I (HLA-I) restricted cytotoxic T cell (CTL) epitopes from influenza virus is of importance for the development of new effective peptide-based vaccines. Methodology/principal...